Abstract
Genetic Engineering & Biotechnology NewsVol. 43, No. 5 Genome EditingMolecular Scissors Are Making the Cut … in Clinical TrialsTreatments based on various genome editing technologies—CRISPR, TALEN, ZFN, and meganuclease technologies—are starting to reach patientsRichard A. SteinRichard A. SteinSearch for more papers by this authorPublished Online:8 May 2023https://doi.org/10.1089/gen.43.05.12AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 5May 2023 Information© 2023 by GEN PublishingTo cite this article:Richard A. Stein.Molecular Scissors Are Making the Cut … in Clinical Trials.Genetic Engineering & Biotechnology News.May 2023.36-38, 40, 41.http://doi.org/10.1089/gen.43.05.12Published in Volume: 43 Issue 5: May 8, 2023PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
